Literature DB >> 10607950

Analysis of all exons of TSC1 and TSC2 genes for germline mutations in Japanese patients with tuberous sclerosis: report of 10 mutations.

Y Yamashita1, J Ono, S Okada, M Wataya-Kaneda, K Yoshikawa, M Nishizawa, Y Hirayama, E Kobayashi, K Seyama, O Hino.   

Abstract

Twenty-seven Japanese patients with the tuberous sclerosis complex (TSC), consisting of 23 sporadic and 4 familial cases, were tested for mutations in the TSC1 and TSC2 genes, using single-strand conformational polymorphism analysis and direct sequencing. Four possible pathogenic mutations were found in the TSC1 gene, including three frame shifts and a nonsense mutation in a familial case. All mutations were expected to result in a truncated hamartin gene product. The TSC2 gene analysis identified six possible pathogenic mutations only in the sporadic cases, including two frame shifts, one in-frame deletion, and three missense mutations. Two of the TSC2 mutations were expected to result in a truncated tuberin gene product. These results of the Japanese TSC patients were compatible with the reports from Europe and the United States, i.e., (1) TSC1 mutations are rarer in sporadic cases than in familial cases, (2) substantial numbers of sporadic cases arise from mutations in the TSC2 gene, and (3) mutations of the TSC1 gene may cause premature truncation of hamartin. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10607950

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  Structure of the Tuberous Sclerosis Complex 2 (TSC2) N Terminus Provides Insight into Complex Assembly and Tuberous Sclerosis Pathogenesis.

Authors:  Reinhard Zech; Stephan Kiontke; Uwe Mueller; Andrea Oeckinghaus; Daniel Kümmel
Journal:  J Biol Chem       Date:  2016-08-04       Impact factor: 5.157

2.  Three independent mutations in the TSC2 gene in a family with tuberous sclerosis.

Authors:  Cédric Le Caignec; David J Kwiatkowski; Sébastien Küry; Jean-Benoit Hardouin; Judith Melki; Albert David
Journal:  Eur J Hum Genet       Date:  2009-03-04       Impact factor: 4.246

3.  Pattern of TSC1 and TSC2 germline mutations in Russian patients with tuberous sclerosis.

Authors:  Evgeny N Suspitsin; Grigoriy A Yanus; Marina Yu Dorofeeva; Tatiana A Ledashcheva; Nataliya V Nikitina; Galina V Buyanova; Elena V Saifullina; Anna P Sokolenko; Evgeny N Imyanitov
Journal:  J Hum Genet       Date:  2018-02-23       Impact factor: 3.172

4.  Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2.

Authors:  David J Kwiatkowski; Michael R Palmer; Sergiusz Jozwiak; John Bissler; David Franz; Scott Segal; David Chen; Julian R Sampson
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

5.  First comprehensive TSC1/TSC2 mutational analysis in Mexican patients with Tuberous Sclerosis Complex reveals numerous novel pathogenic variants.

Authors:  Miriam E Reyna-Fabián; Nancy L Hernández-Martínez; Miguel A Alcántara-Ortigoza; Jorge T Ayala-Sumuano; Sergio Enríquez-Flores; José A Velázquez-Aragón; Alfredo Varela-Echavarría; Carlos G Todd-Quiñones; Ariadna González-Del Angel
Journal:  Sci Rep       Date:  2020-04-20       Impact factor: 4.379

6.  Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms.

Authors:  Louis S Pymar; Fiona M Platt; Jon M Askham; Ewan E Morrison; Margaret A Knowles
Journal:  Hum Mol Genet       Date:  2008-04-07       Impact factor: 6.150

7.  Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing.

Authors:  Magdalena E Tyburczy; Kira A Dies; Jennifer Glass; Susana Camposano; Yvonne Chekaluk; Aaron R Thorner; Ling Lin; Darcy Krueger; David N Franz; Elizabeth A Thiele; Mustafa Sahin; David J Kwiatkowski
Journal:  PLoS Genet       Date:  2015-11-05       Impact factor: 5.917

8.  Mutational analysis of renal angiomyolipoma associated with tuberous sclerosis complex and the outcome of short-term everolimus therapy.

Authors:  Jianxin Ni; Fengqi Yan; Weijun Qin; Lei Yu; Geng Zhang; Fei Liu; Xiaojian Yang; Bo Yang; Chunlin Hao; Teng Wang; Pengfei Liu; Jianlin Yuan; Guojun Wu
Journal:  Sci Rep       Date:  2019-10-04       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.